Merck and Co., which pulled its arthritis painkiller Vioxx from the market late last year after it was linked to heart attacks, is a partner in a new nasal spray that may help fight obesity. The company has just begun clinical trials of the new drug and says reported side effects are minimal so far. The drug suppresses appetite by stimulating the part of the brain that sends the feeling of "fullness" to the stomach.
About the author: Mike Adams is an award-winning natural health author with a passion for teaching people how to improve their health He has authored more than 1,800 articles and dozens of reports, guides and interviews on natural health topics, impacting the lives of millions of readers around the world who are experiencing phenomenal health benefits from reading his articles. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. He has created over 100 CounterThink cartoons and produced several popular hip-hop songs on socially-conscious topics. He also founded an environmentally-friendly online retailer called BetterLifeGoods.com that uses retail profits to help support consumer advocacy programs. He's also a noted pioneer in the email marketing software industry, having been the first to launch an HTML email newsletter technology that has grown to become a standard in the industry. Adams also serves as the executive director of the Consumer Wellness Center, a non-profit consumer protection group, and pursues hobbies such as Pilates, Capoeira, nature macrophotography and organic gardening. Known by his callsign, the 'Health Ranger,' Adams posts his missions statements, health statistics and health photos at www.HealthRanger.org
Email this article to a friend 
Printable Version 
Monday, January 31, 2005
Email this article to a friend
Share this article on: 
